Skyline Diagnostics
Biocartis, SkylineDx Partner to Develop Melanoma Nodal Metastasis Risk Test
The Belgian molecular diagnostics firm also reported a 70 percent year-over-year increase in commercial cartridge volumes in the first quarter.
In Brief This Week: Quest Diagnostics, Biodexis, Caris Life Sciences, SkylineDx, and More
News items for the in vitro diagnostics industry for the week of Feb. 15, 2021.
SkylineDx, Imperial College London, UCSD Partner to Develop Kawasaki Disease Test
The test is based on 13 genes that form a gene signature in the blood of children with Kawasaki disease, and it enables KD to be distinguished from other diseases.
In Brief This Week: SkylineDx, Biocept, Angle, Neoteryx, and More
News items for the in vitro diagnostics industry for the week of June 22, 2020.
SkylineDx, BioInvent Collaborate to Characterize Predictive Immunological Signatures for Cancers
SkylineDx said that the firms will work together to develop predictive immunological signatures for BioInvent's lead therapy candidate.